Celiac Serology Testing: tTG, DGP, EMA, and the Traps

Table of Contents

  1. Why Getting the Order Right Matters
  2. Step One: Always Check Total IgA First
  3. tTG-IgA — The Primary Screen
  4. EMA-IgA — The Confirmatory Test
  5. DGP-IgA and DGP-IgG — The Specialists' Test
  6. Why the Old AGA Test Is Outdated
  7. Titer Magnitude: When Numbers Replace Biopsy
  8. The Critical Trap: You Must Be Eating Gluten
  9. Gluten Challenge Protocols
  10. Seronegative Celiac — When Blood Tests Miss It
  11. Post-Diagnosis: Using tTG to Track Healing
  12. Home and Mail-In Test Kits
  13. Insurance, Coding, and Cost
  14. Pediatric vs Adult Panels
  15. Ordering Pitfalls — What Labs Actually Run
  16. Why Your GI Won't Just "Test You"
  17. Key Research Papers
  18. Research Papers
  19. Connections

Why Getting the Order Right Matters

Celiac disease is one of the most under-diagnosed autoimmune conditions in medicine. Roughly 1% of the population has it, but most walk around undiagnosed for years — some for decades. The reason is almost never that the blood tests are bad. The tests are excellent. The reason is that the tests get ordered wrong, run wrong, or interpreted wrong — and that the patient often is not eating gluten when the blood is drawn, which silently destroys every result on the panel.

This article is the map. It walks through every blood test used to screen for and confirm celiac disease, in the order a smart clinician (or a smart patient advocating for themselves) would use them. It flags the traps that cause false negatives, the rules that let you skip the biopsy in certain cases, and the insurance and lab-order details that decide whether your workup costs $40 or $400.

If you read one section, read The Critical Trap: You Must Be Eating Gluten. That single mistake — going gluten-free before testing — is the number-one reason people get told "you don't have celiac" when they actually do.

Step One: Always Check Total IgA First

Before you order any celiac-specific antibody, a competent workup starts with a total serum IgA level. Here is why.

Most celiac antibodies are IgA class antibodies — they belong to the branch of the immune system that patrols mucosal surfaces, including the lining of the gut. That is a design feature: gluten hits the gut first, so the gut's immune system responds first, and the antibodies it makes are mostly IgA. Unfortunately, 2–3% of people with celiac disease are selective IgA deficient, compared to roughly 0.2% of the general population. If you are in that group, your body simply cannot produce meaningful quantities of IgA, and every IgA-based celiac test will come back falsely negative no matter how sick your gut is.

A total IgA measurement costs around $10–$25 and takes a single extra tube of blood. If it comes back low (typically under 7 mg/dL for adults, lower cutoffs for kids), your clinician switches to IgG-based celiac tests: tTG-IgG and DGP-IgG. If it is normal, you proceed with the standard IgA panel. Skipping this step is the second most common mistake in celiac testing, after drawing blood off-gluten.

tTG-IgA — The Primary Screen

Tissue transglutaminase IgA (tTG-IgA) is the single most important celiac test. It is the first blood test every major guideline body — the American College of Gastroenterology, the European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN), the British Society of Gastroenterology — recommends for anyone with suspected celiac disease. If you are going to order one test, this is it.

What it measures: tissue transglutaminase is the enzyme inside your intestinal lining that modifies gluten peptides after you eat them. In celiac disease, the immune system mistakenly starts producing antibodies against this enzyme. Those antibodies circulate in blood and are easy to detect with an ELISA assay.

The performance is remarkable. In adults eating a normal gluten-containing diet, tTG-IgA has a sensitivity of 93–98% (it catches most cases) and a specificity of 96–99% (it rarely lights up when celiac is absent). No other single gastrointestinal antibody test comes close.

A few caveats you should know:

EMA-IgA — The Confirmatory Test

Endomysial antibody IgA (EMA-IgA) is celiac serology's gold standard for specificity. It is reported as a titer on a dilution series (1:5, 1:10, 1:20, etc.) and uses an old-school immunofluorescence assay, where a technician looks through a microscope at monkey esophagus or human umbilical cord tissue and scores the pattern of antibody binding. It is labor-intensive and operator-dependent, which is why it costs more (roughly $100–$200) and is not the first-line screen.

What it buys you is near-perfect specificity — essentially 100% in experienced labs. A positive EMA-IgA in a symptomatic patient, with a positive tTG-IgA, is so specific for celiac that under the 2020 ESPGHAN pediatric guidelines and the 2022 BSG adult guidelines it can replace the duodenal biopsy in carefully selected cases (see Titer Magnitude).

EMA is not used in isolation. The standard workflow is: screen with tTG-IgA, and if positive (especially if borderline), confirm with EMA-IgA on the same sample or a repeat draw.

DGP-IgA and DGP-IgG — The Specialists' Test

Deamidated gliadin peptide (DGP) antibodies target a chemically modified form of gliadin — the fragment of gluten that the enzyme tissue transglutaminase has "deamidated" inside the gut wall. Think of it as the crime scene residue: if your immune system has been reacting to gluten as processed by celiac gut chemistry, you will usually have anti-DGP antibodies in your blood.

DGP has two main uses:

DGP is not routinely better than tTG for the average adult screen. If your lab offers a "celiac panel" that runs tTG-IgA, EMA-IgA, total IgA, and DGP-IgG all at once, that is fine — comprehensive. If your insurer only pays for one test, tTG-IgA is still the right pick.

Why the Old AGA Test Is Outdated

Older charts sometimes still list anti-gliadin antibody (AGA) — the original celiac blood test from the 1980s. Do not order it. AGA targets native (unprocessed) gliadin and lights up in a wide range of conditions, including non-celiac gluten sensitivity, wheat allergy, Crohn's disease, and healthy wheat eaters with no gut disease at all. Its specificity is poor enough that modern guidelines explicitly recommend against it.

If a provider orders "AGA" or "anti-gliadin IgG/IgA" as part of your celiac workup in 2026, politely ask whether they meant DGP (the modern replacement). Many electronic health records still carry both order sets and the defaults drift.

Titer Magnitude: When Numbers Replace Biopsy

For decades, a duodenal biopsy was mandatory to confirm celiac disease. Then in 2012, ESPGHAN changed pediatric practice: children with a tTG-IgA at or above 10 times the upper limit of normal (≥10× ULN), confirmed by a positive EMA on a second blood draw, plus HLA-DQ2 or DQ8 positivity, could be diagnosed without endoscopy. The 2020 ESPGHAN update dropped the HLA requirement, further simplifying the path.

In 2022, the British Society of Gastroenterology extended a similar option to adults: in carefully selected symptomatic adults with tTG-IgA ≥10× ULN and a positive EMA on a second sample, biopsy is no longer mandatory — though the U.S. American College of Gastroenterology still recommends biopsy for adults in most cases.

Practical takeaway: if your tTG-IgA comes back at, say, 250 U/mL on an assay whose normal is under 20 U/mL, that is a 12× ULN result. Ask your GI whether the biopsy-optional pathway applies in your region. Many countries, including the UK, the Netherlands, and parts of Scandinavia, now routinely skip scopes in high-titer adults. In the U.S., biopsy remains the default but a strong case can be made.

The Critical Trap: You Must Be Eating Gluten

This is the most important paragraph in this article. Every celiac blood test depends on an active immune reaction to gluten. If you stop eating gluten, your tTG-IgA, EMA, and DGP levels begin to fall within weeks, and they will often normalize within three to six months. At that point, the tests cannot distinguish you from a healthy person. A GI who runs celiac serology on a patient who has been gluten-free for months is running a test that is guaranteed to be negative regardless of whether the underlying disease is there.

This happens all the time. A patient feels better after going gluten-free on their own, later asks their doctor "could I have celiac?" and gets blood drawn that same week. The result comes back negative and the patient is told they just have "gluten sensitivity." Months or years later, symptoms return, damage accumulates in the small intestine, and the real diagnosis is missed — sometimes until a vitamin deficiency or osteoporosis forces the question open again.

Rule: do not go gluten-free until celiac has been ruled in or out on an adequate diet. If you are already gluten-free when you decide to get tested, you have two choices: accept that your blood work will be uninformative, or do a gluten challenge to reactivate the antibody response.

Gluten Challenge Protocols

A gluten challenge means eating gluten deliberately, at a meaningful dose, for a defined period so that celiac serology can detect the disease if it is present. The traditional protocol, validated in research settings and still used by most U.S. academic centers:

That is a brutal protocol for someone whose symptoms go away on a gluten-free diet. More recent studies have looked at whether shorter, lower-dose challenges can still trigger detectable antibody and histologic changes. Two reduced protocols now appear in the literature:

If you cannot tolerate a full challenge (some patients get so sick they abandon it), a short challenge followed by both serology and biopsy is still better than nothing — and HLA genetic testing can help: if you are negative for HLA-DQ2 and DQ8, celiac disease is essentially ruled out without any gluten at all (see the HLA genetic testing article).

Seronegative Celiac — When Blood Tests Miss It

Roughly 5–10% of adults with biopsy-proven celiac disease have negative or borderline serology despite eating gluten. The Marsh lesions are there. The villi are blunted. The tTG is stubbornly under the cutoff.

Why this happens is not fully understood. Some patients have very localized, low-grade disease. Some have mild IgA deficiency that falls inside the "normal" range but low enough to suppress tTG-IgA. Some have partially treated celiac from inadvertently reduced-gluten diets before testing.

The practical implication: a negative blood test in a high-suspicion patient is not the end of the workup. If you have iron-deficiency anemia that will not respond to oral iron, unexplained elevated liver enzymes, a first-degree relative with celiac, type 1 diabetes, Hashimoto's thyroiditis, osteoporosis before age 50, or dermatitis herpetiformis, a referral for endoscopic biopsy is appropriate regardless of blood results. See the biopsy and Marsh classification article for what the procedure finds.

Post-Diagnosis: Using tTG to Track Healing

Once you are diagnosed and start a strict gluten-free diet, tTG-IgA becomes one of the cheapest and most useful follow-up tools in medicine. Antibody levels should roughly halve every six months and normalize within 12 to 24 months in most patients on a truly gluten-free diet.

What that means in practice:

Most guidelines recommend tTG-IgA retesting at 6 months, 12 months, and annually thereafter. It does not replace a follow-up endoscopy in complicated cases — villous atrophy can persist even when antibodies normalize — but it catches the majority of dietary slips cheaply.

Home and Mail-In Test Kits

Several direct-to-consumer companies now sell celiac serology by mail: imaware, Everlywell, and a handful of others. You order online, receive a finger-prick or mail-in venous kit, and get results back in one to two weeks. Typical price: $70–$150.

Caveats you should understand before using one:

Home kits are most useful as a screening nudge — "am I in the neighborhood?" — for people whose insurance hassles them about ordering the lab traditionally. They are not a substitute for a proper workup.

Insurance, Coding, and Cost

In the United States, a standard celiac panel (total IgA + tTG-IgA, sometimes with EMA reflex) runs about $40–$120 at LabCorp or Quest on a commercial insurance plan, and commonly costs nothing out-of-pocket when ordered with a documented clinical indication. Relevant CPT codes include 82784 (total IgA), 83516 or 86364 (tTG-IgA), 86255/86256 (EMA titer), and 83516 (DGP variants).

If your insurer pushes back, the magic words in the order are "chronic diarrhea," "iron deficiency anemia," "unexplained weight loss," "family history of celiac disease," or "autoimmune thyroid disease" — all recognized indications that meet medical-necessity criteria.

Without insurance, a cash-pay tTG at a direct-lab service like Ulta Lab Tests or Walk-In Lab runs about $30–$60 — often cheaper than a home kit and including a real draw. This is a reasonable path for uninsured patients.

Pediatric vs Adult Panels

Pediatric and adult panels overlap but are not identical.

Pediatric GI practices tend to be more aggressive about testing first-degree relatives, particularly siblings, because early detection changes growth trajectory and bone density outcomes. Parents of a diagnosed child should expect their other children to be offered testing over the next several years.

Ordering Pitfalls — What Labs Actually Run

A "celiac panel" means different things at different labs. Common variations you may see:

When you see your GI or primary care physician, ask explicitly: "Are you ordering tTG-IgA, total IgA, and DGP-IgG? And EMA if tTG is positive?" That five-second clarification prevents 90% of mis-ordered panels.

Be aware that some electronic health record systems have a default "Celiac Screen" order that includes only tTG-IgA, no total IgA, and no DGP. That is not wrong, but it is not ideal — especially for a first workup.

Why Your GI Won't Just "Test You"

Patients frequently walk into a GI office saying "I've been gluten-free for a year and I want to know if I have celiac. Can you just test me?" The answer, almost always, is no — not usefully. Here is what the GI hears and why they push back:

The realistic options, if you are already gluten-free and want a definitive answer:

A good GI will lay out all three paths and let you choose. If yours refuses to test you but will not explain the reasoning, bring this article to the next appointment.

Key Research Papers

Research Papers

For further reading, the following PubMed topic searches return current peer-reviewed work on celiac serology performance, gluten challenge protocols, and follow-up monitoring:

  1. tTG-IgA sensitivity and specificity for celiac disease
  2. Endomysial antibody testing in celiac disease
  3. Deamidated gliadin peptide (DGP) antibodies
  4. IgA deficiency and celiac disease screening
  5. Gluten challenge protocols and short-course challenges
  6. Seronegative celiac disease
  7. tTG follow-up and gluten-free diet adherence
  8. ESPGHAN no-biopsy pathway and high-titer tTG

Connections

Back to Table of Contents